Related Experiment Video
Updated: Jul 16, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
ECG left ventricular hypertrophy in aortic stenosis: Relationship with cardiac structure, invasive hemodynamics, and
Patrizia Sager1,2, Andreas Rusch1,3, Lukas Weber1
1Department of Cardiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Insights
The Peguero-Lo Presti score effectively predicts left ventricular hypertrophy and cardiac damage in severe aortic stenosis patients. This ECG-based score also indicates long-term mortality risk following aortic valve replacement.
Area of Science:
- Cardiology
- Medical Diagnostics
- Cardiac Surgery
Background:
- Left ventricular hypertrophy (LVH) is a response to pressure overload in aortic stenosis (AS).
- AS-related cardiac damage can follow LVH, impacting patient prognosis.
- Electrocardiogram (ECG) LVH may predict cardiac damage and outcomes after aortic valve replacement (AVR).
Purpose of the Study:
- To evaluate if ECG-derived LVH predicts echocardiographic LVH in AS patients.
- To determine if ECG-derived LVH predicts other markers of cardiac damage.
- To assess the prognostic value of ECG LVH for mortality after AVR.
Main Methods:
- 279 severe AS patients undergoing ECG, echocardiography, and cardiac catheterization before AVR were studied.
- Sokolow-Lyon index, Cornell product, Romhilt-Estes score, and Peguero-Lo Presti score were assessed.
- Correlation with echocardiographic LVH, invasive cardiac damage markers, and all-cause mortality post-AVR was analyzed.
Main Results:
- The Peguero-Lo Presti score showed the highest AUC for predicting echocardiographic LVH.
- This score also best predicted invasive measures of cardiac damage, including elevated filling pressures and pulmonary resistance.
- The Peguero-Lo Presti score was significantly associated with all-cause mortality after AVR.
Conclusions:
- The Peguero-Lo Presti score is a valuable tool for assessing cardiac abnormalities in severe AS.
- It correlates with LVH, invasive cardiac damage markers, and predicts long-term mortality post-AVR.
- ECG assessment using the Peguero-Lo Presti score can aid in risk stratification for AS patients.
Background:
In aortic stenosis (AS), left ventricular hypertrophy (LVH) is the response to pressure overload and represents the substrate for a maladaptive cascade, the so-called AS-related cardiac damage. We hypothesized that in AS patients electrocardiogram (ECG) LVH not only predicts echocardiography LVH but also other noninvasive and invasive markers of cardiac damage and prognosis after aortic valve replacement (AVR).
Methods:
In 279 patients with severe AS undergoing ECG, echocardiography, and cardiac catheterization before AVR, the Sokolow-Lyon index, the Cornell product, the Romhilt-Estes score, and the Peguero-Lo Presti score were assessed.
Results:
The mean left ventricular mass index was 109 ± 34 g/m2 , and 131 (47%) patients had echocardiography LVH. The areas under the receiver operator characteristics curve (AUC) for the Sokolow-Lyon index, the Cornell product, the Romhilt-Estes score, and the Peguero-Lo Presti score for the prediction of echocardiography LVH were 0.59, 0.70, 0.63, and 0.65. The Peguero-Lo Presti score had the numerically greatest AUC for the prediction of left ventricular end-diastolic pressure >15 mmHg, mean pulmonary artery wedge pressure >15 mmHg, pulmonary vascular resistance >3 Wood units, mean right atrial pressure >14 mmHg, and stroke volume index <31 mL/m2 . After a median follow-up of 1365 (interquartile range: 931-1851) days after AVR only the Peguero-Lo Presti score was significantly associated with all-cause mortality [hazard ratio: 1.24 (95% confidence interval: 1.01-1.54); per 1 mV increase; p = .045].
Conclusions:
Among severe AS patients, the Peguero-Lo Presti score is associated with abnormalities in cardiac structure including LVH, invasive measures of cardiac damage, and long-term mortality after AVR.
More Related Videos
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
06:51Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis I: Introduction
Heart Failure II: Pathophysiology
Aortic Regurgitation I: Introduction
Mitral Regurgitation I: Introduction